Stay updated on Sepofarsen Repeat-dose in LCA10 Clinical Trial
Sign up to get notified when there's something new on the Sepofarsen Repeat-dose in LCA10 Clinical Trial page.

Latest updates to the Sepofarsen Repeat-dose in LCA10 Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedAccess to the study record now displays a 403 Forbidden page, replacing the study content. The additions include a 403 snippet and 'Revision: v3.7.0', while sponsor and MeSH-related metadata were removed.SummaryDifference20%

- Check36 days agoChange DetectedThe page now includes an NIH grant/contract annotation for 2018. The page revision has been updated from v3.6.5 to v3.6.6.SummaryDifference0.2%

- Check50 days agoChange DetectedSponsor and collaborators information, along with expanded MeSH terms and keywords, have been added to the study record to improve attribution and searchability. The changes also incorporate references like Plan for IPD and related terminology to better describe the study and its context.SummaryDifference69%

- Check57 days agoChange DetectedThe page revision has been updated to v3.6.5, replacing v3.6.4, indicating a minor metadata update to the page.SummaryDifference0.0%

- Check64 days agoChange DetectedNo changes were recorded in the provided data; the page content remains as previously captured.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4. This reflects a small refresh of the page without changes to the study data.SummaryDifference0.1%

Stay in the know with updates to Sepofarsen Repeat-dose in LCA10 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sepofarsen Repeat-dose in LCA10 Clinical Trial page.